Comparative study of the pharmacokinetic profiles of two LMWHs-bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)-administered subcutaneously to healthy male volunteers

Author： Depasse F.   Gonzalez de Suso M.J.   Lagoutte I.   Fontcuberta J.   Borrell M.   Samama M.M.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.109, Iss.2, 2003-01, pp. : 109-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor

By Hara T.   Yokoyama A.   Morishima Y.   Kunitada S.  

Thrombosis Research, Vol. 80, Iss. 1, 1995-10 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Body Weight Does Not Predict for Anti-Xa Levels after Fixed Dose Prophylaxis with Enoxaparin After Orthopedic Surgery - The post-arthroplasty screening study

By Kovacs M.J.   Weir K.   MacKinnon K.   Keeney M.   Brien W.F.   Cruickshank M.K.  

Thrombosis Research, Vol. 91, Iss. 3, 1998-08 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention

By Lombo Bernardo   Dííez Joséé G  

Future Cardiology, Vol. 7, Iss. 3, 2011-05 ,pp. : 281-285

Future Medicine

Access to resources Recommend Favorite

Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series

By Deal Eli  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 188-194

Springer Publishing Company

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite